No Dry Fusion Eye

No Dry Fusion Eye Uses, Dosage, Side Effects, Food Interaction and all others data.

The higher strength of Carboxymethylcellulose Sodium USP-NF provides long-lasting relief from dryness by forming a soothing gel after administration of the drops on to the eyes.

In a randomized clinical study of patients with mild or moderate forms of eye dryness, ophthalmic treatment with sodium carboxymethylcellulose resulted in a diminished frequency of symptoms compared to the placebo group . Carboxymethylcellulose interacts with human corneal epithelial cells to facilitate corneal epithelial wound healing and attenuate eye irritation in a dose-dependent manner . It exhibits protective actions on the ocular surface in various applications; it mediates cytoprotective effects on the ocular surface when applied prior to contact lenses and reduces the incidence of epithelial defects during LASIK .

Sodium hyaluronate is a polysaccharide which functions as a tissue lubricant. It is widely used in ophthalmic surgery because it forms a viscoelastic solution in water which makes it a suitable substitute for aqueous and vitreous humour.

Trade Name No Dry Fusion Eye
Generic Carboxymethylcellulose + Sodium Hyaluronate
Type Drops
Therapeutic Class
Manufacturer Akumentis Healthcare Ltd
Available Country India
Last Updated: September 19, 2023 at 7:00 am
No Dry Fusion Eye
No Dry Fusion Eye

Uses

Carboxymethylcellulose Sodium is used as a lubricant to relieve irritation and discomfort due to dryness of the eye or due to exposure to wind or sun.

Sodium Hyaluronate is used for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics, e.g., acetaminophen.

Sodium Hyaluronate is a viscous solution consisting of a high molecular weight fraction of purified natural sodium hyaluronate in buffered physiological sodium phosphate. It has a pH of 5.5-7.0. Hyaluronic acid is an important component of the body's extracellular matrix and is present in a particularly high concentration in cartilage and synovial fluid. Endogenous hyaluronic acid provides viscosity and elasticity to synovial fluid, which is fundamental for its lubricating and shock absorbing properties. It is essential for the correct structure of proteoglycans in articular cartilage. In osteoarthritis there is an insufficient amount of and a chance in the quality of hyaluronic acid in synovial fluid and cartilage. The intra-articular administration of hyaluronic acid into arthritic joints with degenerating cartilage surfaces and pathologically altered synovial fluid improved functions.

No Dry Fusion Eye is also used to associated treatment for these conditions: Dry Eyes, Ocular Irritation

How No Dry Fusion Eye works

Carboxymethylcellulose binds to the surface of corneal epithelial cells via its glucopyranose subunits binding to glucose receptors GLUT-1 . The residence time of carboxymethylcellulose bound to corneal cells is approximately 2 hours as indicated by a short-term binding assay . Binding of carboxymethylcellulose to the matrix proteins stimulated corneal epithelial cell attachment, migration, and re-epithelialization of corneal wounds .

Dosage

No Dry Fusion Eye dosage

Install 1 or 2 drops in the affected eye(s) as needed or as directed by the physician.

Sodium Hyaluronate is administered by intra-articular injection. A treatment cycle consists of five injections given at weekly intervals. Some patients may experience benefit with three injections given at weekly intervals. Inject the full 2 ml in one knee only. If treatment is bilateral, a separate injection should be used for each knee.

Side Effects

Visual disturbances, ocular discharge and eye pruritus are common adverse drug reactions were reported with Carboxymethylcellulose Sodium

The common side-effects include gastrointestinal complaints, injection site pain, knee swelling/effusion, local skin reactions (rash, ecchymosis), pruritus, and headache.

Toxicity

Rat oral LD50, rabbit dermal LD50, and rat inhalation LC50 of sodium carboxymethyl cellulose are 27000 mg/kg, >2 g/kg, and >5800 mg/m^3 (4 hours), respectively .

Precaution

Concomitant ocular medication should be administered 15 minutes apart to the instillation of this eye drop.

Use caution when injecting Sodium Hyaluronate into patients who are allergic to avian proteins, feathers, and egg products. Strict aseptic administration technique must be followed. Remove joint effusion, if present, before injecting Sodium Hyaluronate. Do not use the same syringe for removing joint effusion and for injecting Sodium Hyaluronate. It is recommended that the patient avoid any strenuous activities or prolonged (i.e., more than 1 hour) weight-bearing activities such as jogging or tennis within 48 hours following the intra-articular injection.

Interaction

No information is available.

Volume of Distribution

No pharmacokinetic data available.

Elimination Route

No pharmacokinetic data available.

Half Life

No pharmacokinetic data available.

Clearance

No pharmacokinetic data available.

Elimination Route

No pharmacokinetic data available.

Pregnancy & Breastfeeding use

Use in Pregnancy: There is no data on the use of Carboxymethylcellulose Sodium 1% during pregnancy and lactation in human. Animal studies did not show harmful effects with the active ingredient Carboxymethylcellulose Sodium. Use in Lactation: Carboxymethylcellulose Sodium is not absorbed systemically; there is no known potential for excretion in human breast milk.

Pediatric use: The safety and effectiveness in pediatric patients have not been established.

The safety and effectiveness of Sodium Hyaluronate have not been established in pregnant women. It is not known if Sodium Hyaluronate is excreted in human milk. The safety and effectiveness of Sodium Hyaluronate have not been established in lactating mother. The safety and effectiveness of Sodium Hyaluronate have not been demonstrated in children.

Contraindication

Contraindicated in patients who are hypersensitive to any of the components of Carboxymethylcellulose Sodium.

The drug is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of past and present infections or skin diseases in the area of the injection site.

Special Warning

Use in children: No information available.

Use in elderly patients: No information available.

Acute Overdose

Since CMC is pharmacologically inert and not expected to be absorbed systemically, systemic effects from topical overdose are not expected from the administration of Carboxymethylcellulose sodium (Cellufresh) 0.5%. Additionally, no toxic side effects are expected should accidental systemic overdose occur.

No case of over dosage has been reported to date.

Storage Condition

Store in a cool, dry place and protect from light. Keep out of the reach of children.

Hyronate injection should be stored in a cool (below 25° C) and dry place and protected from light. Protect from freezing.

Innovators Monograph

You find simplified version here No Dry Fusion Eye


*** Taking medicines without doctor's advice can cause long-term problems.
Share